{"id":3587,"date":"2021-04-14T12:30:51","date_gmt":"2021-04-14T12:30:51","guid":{"rendered":"https:\/\/www.reseau-amylose.org\/jesuissoignant\/?page_id=3587"},"modified":"2024-09-18T15:13:03","modified_gmt":"2024-09-18T13:13:03","slug":"les-traitements-des-atteintes-cardiaques-des-amyloses-al","status":"publish","type":"page","link":"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/","title":{"rendered":"Les traitements des amyloses AL"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Les traitements des amyloses AL<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Les traitements de l'amylose<\/h2><\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Traitement sp\u00e9cifique de l'amylose AL<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Le traitement des amyloses AL a beaucoup \u00e9volu\u00e9 et l\u2019utilisation de nouvelles chimioth\u00e9rapies et immunoth\u00e9rapie ont permis d\u2019am\u00e9liorer consid\u00e9rablement le pronostic des patients. Il est fr\u00e9quent d\u2019observer une r\u00e9gression de l\u2019infiltration et une am\u00e9lioration des sympt\u00f4mes.\u00a0<\/span><\/p>

Un compos\u00e9 du th\u00e9 vert (Epigallocatechin-3-gallate (EGCG)) a \u00e9galement montr\u00e9 son int\u00e9r\u00eat pour r\u00e9duire la masse ventriculaire mesur\u00e9e en \u00e9chocardiographie et en IRM dans une \u00e9tude non randomis\u00e9e de faible effectif.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Les traitements de l'amylose AL<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Arnaud JACCARD<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Comment utiliser la cytog\u00e9n\u00e9tique pour mieux traiter les amyloses AL<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Fabien LE BRAS<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Chimioth\u00e9rapies dans l'amylose AL : ce que le cardiologue doit savoir<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Dania MOHTY<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Chimioth\u00e9rapies dans les amyloses AL et impact pour le coeur<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Thibaud DAMY<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Cons\u00e9quences cardiaques de la dexam\u00e9thasone dans l'amylose cardiaque AL<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

M\u00e9lanie BEZARD<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Int\u00e9r\u00eat de la dexam\u00e9thasone dans l'amylose AL<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Arnaud JACCARD<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Le Daratumumab pour traiter les amyloses AL<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Antoine HUART<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Les traitements des amyloses AL IIIA et IIIB - Partage des organisations r\u00e9gionales<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Le parcours de soin des Amyloses AL IIIA et IIIB (European staging)<\/span><\/p>

Les amyloses AL avec une atteinte cardiaque doivent \u00eatre g\u00e9r\u00e9es de mani\u00e8re multidisciplinaire avec h\u00e9matologues, cardiologues, n\u00e9phrologues, etc.\u00a0<\/span><\/p>

Dans chaque r\u00e9gion, les centres du R\u00e9seau Amylose se sont organis\u00e9s pour pouvoir prendre en charge de mani\u00e8re multiprofessionnelle et interdisciplinaire les patients atteints d’amylose cardiaque au stade IIIA ou IIIB.\u00a0<\/span><\/p>

Dans les trois vid\u00e9os ci-dessous, retrouvez les organisations d\u00e9velopp\u00e9es par le CHU Henri Mondor, le CHU de Rangueuil et les H\u00f4pitaux Civils de Lyon.\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

La prise en charge \u00e0 Lyon<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Antoine JOBBE-DUVAL<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

La prise en charge \u00e0 Toulouse<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Eve CARIOU<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

La prise en charge \u00e0 Cr\u00e9teil<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Amira ZAROUI<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
R\u00e9f\u00e9rences<\/strong><\/span><\/h5>
1. Molecular Mechanisms of Amyloidosis. Merlini G. and Bellotti V.N Engl Med 2003;349:583-96<\/a><\/h5>
2. Familial amyloid polyneuropathy A clinico-pathologic study. Said G, Plant\u00e9-Bordeneuve V. Journal of the Neurological Sciences 284 (2009) 149\u2013154.<\/a><\/h5>
3. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS,Buxbaum JN. N Engl J Med 1997;336:466\u2013473.<\/a><\/h5>
4. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Dermot Phelan, Collier P,\u00a0Popovi\u0107 Z,Hanna M,\u00a0Plana JC, Marwick TH,\u00a0Thomas JD. \u00a0Heart\u00a02012;98:1442-1448.<\/a><\/h5>
5. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Perugini E,\u00a0Rapezzi C,\u00a0Piva T,\u00a0Leone O,\u00a0Bacchi-Reggiani L,\u00a0Riva L,\u00a0Salvi F,\u00a0Lovato L,\u00a0Branzi A,\u00a0Fattori R. Heart.\u00a02006 Mar;92(3):343-9.<\/a><\/h5>
6. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Feng D, Edwards WD, Oh JK, Chandrasekaran K, Grogan M, Martinez MW, Syed IS, Hughes DA, Lust JA, Jaffe AS, Gertz MA, Klarich KW. Circulation 2007;116:2420\u20132426.<\/a><\/h5>
7. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. Rapezzi C, Quarta CC, Guidalotti PL, Pettinato C, Fanti S, Leone O, Ferlini A, Longhi S, Lorenzini M, Reggiani LB, Gagliardi C, Gallo P, Villani C, Salvi F. JACC Cardiovasc Imaging. 2011 Jun;4(6):659-70. <\/a><\/h5><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Les traitements des amyloses AL Les traitements de l’amylose Traitement sp\u00e9cifique de l’amylose AL Le traitement des amyloses AL a beaucoup \u00e9volu\u00e9 et l\u2019utilisation de nouvelles chimioth\u00e9rapies et immunoth\u00e9rapie ont permis d\u2019am\u00e9liorer consid\u00e9rablement le pronostic des patients. Il est fr\u00e9quent d\u2019observer une r\u00e9gression de l\u2019infiltration et une am\u00e9lioration des sympt\u00f4mes.\u00a0 Un compos\u00e9 du th\u00e9 vert […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[],"tags":[],"class_list":["post-3587","page","type-page","status-publish","hentry"],"yoast_head":"\nLes traitements des amyloses AL - R\u00e9seau Amylose<\/title>\n<meta name=\"description\" content=\"Les traitements sp\u00e9cifiques des amyloses AL - cytog\u00e9n\u00e9tique, chimioth\u00e9rapie, etc. - la prise en charge dans les centres experts\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les traitements des amyloses AL - R\u00e9seau Amylose\" \/>\n<meta property=\"og:description\" content=\"Les traitements sp\u00e9cifiques des amyloses AL - cytog\u00e9n\u00e9tique, chimioth\u00e9rapie, etc. - la prise en charge dans les centres experts\" \/>\n<meta property=\"og:url\" content=\"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/\" \/>\n<meta property=\"og:site_name\" content=\"R\u00e9seau Amylose\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-18T13:13:03+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/\",\"url\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/\",\"name\":\"Les traitements des amyloses AL - R\u00e9seau Amylose\",\"isPartOf\":{\"@id\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/#website\"},\"datePublished\":\"2021-04-14T12:30:51+00:00\",\"dateModified\":\"2024-09-18T13:13:03+00:00\",\"description\":\"Les traitements sp\u00e9cifiques des amyloses AL - cytog\u00e9n\u00e9tique, chimioth\u00e9rapie, etc. - la prise en charge dans les centres experts\",\"breadcrumb\":{\"@id\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les traitements des amyloses AL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/#website\",\"url\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/\",\"name\":\"R\u00e9seau Amylose\",\"description\":\"Centre de r\u00e9f\u00e9rence des amyloses cardiaques espace soignant\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/reseau-amylose.org\/jesuissoignant\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les traitements des amyloses AL - R\u00e9seau Amylose","description":"Les traitements sp\u00e9cifiques des amyloses AL - cytog\u00e9n\u00e9tique, chimioth\u00e9rapie, etc. - la prise en charge dans les centres experts","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/","og_locale":"fr_FR","og_type":"article","og_title":"Les traitements des amyloses AL - R\u00e9seau Amylose","og_description":"Les traitements sp\u00e9cifiques des amyloses AL - cytog\u00e9n\u00e9tique, chimioth\u00e9rapie, etc. - la prise en charge dans les centres experts","og_url":"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/","og_site_name":"R\u00e9seau Amylose","article_modified_time":"2024-09-18T13:13:03+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/","url":"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/","name":"Les traitements des amyloses AL - R\u00e9seau Amylose","isPartOf":{"@id":"https:\/\/reseau-amylose.org\/jesuissoignant\/#website"},"datePublished":"2021-04-14T12:30:51+00:00","dateModified":"2024-09-18T13:13:03+00:00","description":"Les traitements sp\u00e9cifiques des amyloses AL - cytog\u00e9n\u00e9tique, chimioth\u00e9rapie, etc. - la prise en charge dans les centres experts","breadcrumb":{"@id":"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/reseau-amylose.org\/jesuissoignant\/les-traitements-des-atteintes-cardiaques-des-amyloses-al\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/reseau-amylose.org\/jesuissoignant\/"},{"@type":"ListItem","position":2,"name":"Les traitements des amyloses AL"}]},{"@type":"WebSite","@id":"https:\/\/reseau-amylose.org\/jesuissoignant\/#website","url":"https:\/\/reseau-amylose.org\/jesuissoignant\/","name":"R\u00e9seau Amylose","description":"Centre de r\u00e9f\u00e9rence des amyloses cardiaques espace soignant","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/reseau-amylose.org\/jesuissoignant\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/pages\/3587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/comments?post=3587"}],"version-history":[{"count":29,"href":"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/pages\/3587\/revisions"}],"predecessor-version":[{"id":6915,"href":"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/pages\/3587\/revisions\/6915"}],"wp:attachment":[{"href":"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/media?parent=3587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/categories?post=3587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/reseau-amylose.org\/jesuissoignant\/wp-json\/wp\/v2\/tags?post=3587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}